RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 91 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $672,711 | +258.1% | 29,344 | +157.6% | 0.01% | +250.0% |
| Q2 2023 | $187,871 | +40564.7% | 11,393 | -56.0% | 0.00% | -71.4% |
| Q1 2023 | $462 | -100.0% | 25,874 | -69.1% | 0.01% | -84.1% |
| Q3 2022 | $2,053,000 | +294.8% | 83,796 | -33.2% | 0.04% | +214.3% |
| Q2 2022 | $520,000 | -11.9% | 125,416 | +144.8% | 0.01% | 0.0% |
| Q1 2022 | $590,000 | +100.7% | 51,238 | +73.8% | 0.01% | +180.0% |
| Q4 2021 | $294,000 | -79.3% | 29,478 | -55.9% | 0.01% | -82.8% |
| Q1 2021 | $1,422,000 | +485.2% | 66,852 | +761.7% | 0.03% | +262.5% |
| Q2 2018 | $243,000 | – | 7,758 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $11,875,000 | 2.75% |
| RA Capital Management | 4,871,067 | $63,616,000 | 0.88% |
| NEA Management Company, LLC | 4,912,306 | $64,155,000 | 0.76% |
| Samsara BioCapital, LLC | 300,293 | $3,922,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,989,625 | $25,985,000 | 0.51% |
| Baker Brothers Advisors | 3,863,239 | $50,454,000 | 0.22% |
| ACT CAPITAL MANAGEMENT, LLC | 31,000 | $405,000 | 0.21% |
| Rock Springs Capital Management LP | 612,180 | $7,995,000 | 0.17% |
| GILDER GAGNON HOWE & CO LLC | 1,496,424 | $19,543,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,011,053 | $39,324,000 | 0.08% |